MONTREAL—Quebec’s universal pharmacare system, which relies on both a public plan and private insurance providers, covers more drugs and provides quicker access to new medicines than other Canadian provinces, finds a new study released today by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.
Last month, a federally-appointed advisory panel (headed by former Ontario health minister Dr. Eric Hoskins) released a report calling for a government-run taxpayer-funded national pharmacare program—vastly different from Quebec’s system.
